Home » Newsletters » BioWorld

BioWorld

July 8, 1992

View Archived Issues

ANTISENSE DRUG FARING WELL IN SAFETY TRIALS

Ribi To Expand Manufacturing Facility

PPL RAISES $11.6 MILLION IN FINANCING

WAITING PERIOD EXPIRES FOR SCIOS-NOVA MERGER

IMMUNOMEDICS FOUNDER STEPS ASIDE

ELAN STOCK PURCHASE AUTHORIZED

OPPENHEIMER FUNDS INVEST IN PGS

GENE THERAPY FOR CF GETS ORPHAN DESIGNATION

ECOSCIENCE CRADA FOR BIOFUNGICIDE

AMGEN, CELLPRO TEAM FOR CANCER TRIALS